Novocure Ltd
NASDAQ:NVCR

Watchlist Manager
Novocure Ltd Logo
Novocure Ltd
NASDAQ:NVCR
Watchlist
Price: 18.74 USD -1.21% Market Closed
Market Cap: 2.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+20%
Revenue
Forecast
+8%
Net Income
Forecast
+10%

Wall Street
Price Targets

NVCR Price Targets Summary
Novocure Ltd

Wall Street analysts forecast NVCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVCR is 36.28 USD with a low forecast of 29.29 USD and a high forecast of 44.1 USD.

NVCR Lowest Forecast
Wall Street Target
29.29 USD
56% Upside
NVCR Average Forecast
Wall Street Target
36.28 USD
94% Upside
NVCR Highest Forecast
Wall Street Target
44.1 USD
135% Upside
Lowest
Price Target
29.29 USD
56% Upside
Average
Price Target
36.28 USD
94% Upside
Highest
Price Target
44.1 USD
135% Upside
Novocure Ltd Competitors:
Price Targets
ABT
Abbott Laboratories
7% Upside
BFLY
Butterfly Network Inc
115% Upside
CLPT
Clearpoint Neuro Inc
96% Upside
DCTH
Delcath Systems Inc
71% Upside
ABT
Abbott Laboratories
7% Upside
BFLY
Butterfly Network Inc
115% Upside
CLPT
Clearpoint Neuro Inc
96% Upside
DCTH
Delcath Systems Inc
71% Upside
TNDM
Tandem Diabetes Care Inc
123% Upside
AXGN
AxoGen Inc
40% Upside
HOLX
Hologic Inc
32% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Novocure Ltd

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 28%. The projected CAGR for the next 3 years is 10%.

28%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

See Also

Summary
NVCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
NVCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NVCR stock valuation using valuation multiples.
Wall Street Estimates
NVCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NVCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVCR's stock price target?
Price Target
36.28 USD

According to Wall Street analysts, the average 1-year price target for NVCR is 36.28 USD with a low forecast of 29.29 USD and a high forecast of 44.1 USD.

What is Novocure Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 28%. The projected CAGR for the next 3 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.